|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 279, Issue 1, 77-85, January 2, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid*
From the
Cytochroma Inc., Markham, Ontario L3R 8E4 and ¶Cancer Research Laboratories, Queen's University, Kingston, Ontario K7L 3N6, Canada
Retinoids are potent regulators of cell proliferation, cell differentiation, and morphogenesis and are important therapeutic agents in oncology and dermatology. The gene regulatory activity of endogenous retinoids is effected primarily by retinoic acid isomers (all-trans and 9-cis) that are synthesized from retinaldehyde precursors in a broad range of tissues and act as ligands for nuclear retinoic acid receptors. The catabolism of all-trans-retinoic acid (atRA) is an important mechanism of controlling RA levels in cell and tissues. We have previously identified two cytochrome P450s, P450RAI-1 and P450RAI-2 (herein named CYP26A1 and CYP26B1), which were shown to be responsible for catabolism of atRA both in the embryo and the adult. In this report, we describe the identification, molecular cloning, and substrate characterization of a third member of the CYP26 family, named CYP26C1. Transiently transfected cells expressing CYP26C1 convert atRA to polar water-soluble metabolites similar to those generated by CYP26A1 and -B1. Competition studies with all-trans, 13-cis, and 9-cis isomers of retinoic acid demonstrated that atRA was the preferred substrate for CYP26C1. Although CYP26C1 shares extensive sequence similarity with CYP26A1 and CYP26B1, its catalytic activity appears distinct from those of other CYP26 family members. Specifically, CYP26C1 can also recognize and metabolize 9-cis-RA and is much less sensitive than the other CYP26 family members to the inhibitory effects of ketoconazole. CYP26C1 is not widely expressed in the adult but is inducible by RA in HPK1a, transformed human keratinocyte cell lines. This third CYP26 member may play a specific role in catabolizing both all-trans and 9-cis isomers of RA.
Received for publication, July 30, 2003 , and in revised form, October 6, 2003.
* This work was supported in part by Cytochroma Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| Supported by the National Cancer Institute of Canada, Canadian Institute of Health Research and Cytochroma Inc.
To whom correspondence should be addressed: Cytochroma Inc., 330 Cochrane Drive, Markham, Ontario L3R 8E4, Canada. Tel.: 905-479-5306 (ext. 326); Fax: 905-479-1287; E-mail: bozena{at}cytochroma.com.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-K. Kim, L. Wassef, L. Hamberger, R. Piantedosi, K. Palczewski, W. S. Blaner, and L. Quadro Retinyl Ester Formation by Lecithin:Retinol Acyltransferase Is a Key Regulator of Retinoid Homeostasis in Mouse Embryogenesis J. Biol. Chem., February 29, 2008; 283(9): 5611 - 5621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Muindi, M. D. Roth, R. A. Wise, J. E. Connett, G. T. O'Connor, J. W. Ramsdell, N. W. Schluger, M. Romkes, R. A. Branch, F. C. Sciurba, et al. Pharmacokinetics and Metabolism of All-trans- and 13-cis-Retinoic Acid in Pulmonary Emphysema Patients J. Clin. Pharmacol., January 1, 2008; 48(1): 96 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Oppenheimer, N.-K. Cheung, and W. L. Gerald The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma Mol. Cancer Ther., April 1, 2007; 6(4): 1300 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zolfaghari, C. J. Cifelli, S. O. Lieu, Q. Chen, N.-q. Li, and A. C. Ross Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1029 - G1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Hernandez, A. P. Putzke, J. P. Myers, L. Margaretha, and C. B. Moens Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development Development, January 1, 2007; 134(1): 177 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Osanai, N. Nishikiori, M. Murata, H. Chiba, T. Kojima, and N. Sawada Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor {alpha} Agonists in Colitis Mol. Pharmacol., January 1, 2007; 71(1): 250 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Roberts, S. Ivins, A. C. Cook, A. Baldini, and P. J. Scambler Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick Hum. Mol. Genet., December 1, 2006; 15(23): 3394 - 3410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gu, F. Xu, W. Song, X. Wang, P. Hu, Y. Yang, X. Gao, and Q. Zhao A Novel Cytochrome P450, Zebrafish Cyp26D1, Is Involved in Metabolism of All-trans Retinoic Acid Mol. Endocrinol., July 1, 2006; 20(7): 1661 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Dlugaszewska, A Silahtaroglu, C Menzel, S Kubart, M Cohen, S Mundlos, Z Tumer, K Kjaer, U Friedrich, H-H Ropers, et al. Breakpoints around the HOXD cluster result in various limb malformations J. Med. Genet., February 1, 2006; 43(2): 111 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Vernet, C. Dennefeld, C. Rochette-Egly, M. Oulad-Abdelghani, P. Chambon, N. B. Ghyselinck, and M. Mark Retinoic Acid Metabolism and Signaling Pathways in the Adult and Developing Mouse Testis Endocrinology, January 1, 2006; 147(1): 96 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sen, S. Harpavat, M. A. Peters, and C. L. Cepko Retinoic acid regulates the expression of dorsoventral topographic guidance molecules in the chick retina Development, December 1, 2005; 132(23): 5147 - 5159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Moise, V. Kuksa, W. S. Blaner, W. Baehr, and K. Palczewski Metabolism and Transactivation Activity of 13,14-Dihydroretinoic Acid J. Biol. Chem., July 29, 2005; 280(30): 27815 - 27825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Osanai and M. Petkovich Expression of the Retinoic Acid-Metabolizing Enzyme CYP26A1 Limits Programmed Cell Death Mol. Pharmacol., May 1, 2005; 67(5): 1808 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Moise, V. Kuksa, Y. Imanishi, and K. Palczewski Identification of All-trans-Retinol:All-trans-13,14-dihydroretinol Saturase J. Biol. Chem., November 26, 2004; 279(48): 50230 - 50242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Villani, V. Appierto, E. Cavadini, M. Valsecchi, S. Sonnino, R. W. Curley, and F. Formelli Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1 Clin. Cancer Res., September 15, 2004; 10(18): 6265 - 6275. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |